Clinical Outcomes of Drug-Coated Balloon in Coronary Patients with and without Diabetes Mellitus: A Multicenter, Propensity Score Study

Table 3

Risk of primary and secondary outcomes in the propensity score-matched cohort at one-year follow-up.

Endpoint	All patients				Propensity matched sample
	Without DM	With DM	Odds ratio (95% CI)	value	Without DM	With DM	Odds ratio (95% CI)	value
Number of patients	1490	816			578	578
TLF	36 (2.42%)	37 (4.53%)	1.918 (1.203, 3.060)	0.005	16 (2.77%)	31 (5.36%)	1.991 (1.077, 3.681)	0.025
TLR	24 (1.61%)	29 (3.55%)	2.251 (1.302, 3.893)	0.003	11 (1.90%)	24 (4.15%)	2.233 (1.083, 4.602)	0.026
MACE†	45 (3.02%)	44 (5.39%)	1.830 (1.197, 2.798)	0.005	22 (3.81%)	34 (5.88%)	1.580 (0.912, 2.735)	0.100
Cardiac death	11 (0.74%)	8 (0.98%)	1.331 (0.533, 3.323)	0.539	2 (0.87%)	8 (1.38%)	1.608 (0.523, 4.946)	0.403
MI	3 (0.20%)	10 (1.23%)	6.150 (1.688, 22.409)	0.002	2 (0.35%)	8 (1.38%)	4.042 (0.855, 19.117)	0.057
Any revascularization‡	81 (5.44%)	68 (8.33%)	1.581 (1.132, 2.209)	0.007	35 (6.06%)	52 (9.00%)	1.534 (0.983, 2.393)	0.058

DM: diabetes mellitus; CI: confidence interval; TLF: target lesion failure; TLR: target lesion revascularization; MACE: major adverse cardiovascular events; MI: myocardial infraction. †MACE defined as the composite outcome of cardiac death, myocardial infarction, and target vessel revascularization. ‡Any revascularization includes any percutaneous coronary intervention and coronary artery bypass grafting.